首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >A COMPARATIVE STUDY OF ‘BELLADONNA-200’ AND JE VACCINE (SA-14-14-2) IN PREVENTION OF JAPANESE ENCEPHALITIS IN SWISS ALBINO MICE
【24h】

A COMPARATIVE STUDY OF ‘BELLADONNA-200’ AND JE VACCINE (SA-14-14-2) IN PREVENTION OF JAPANESE ENCEPHALITIS IN SWISS ALBINO MICE

机译:“ BELLADONNA-200”和JE疫苗(SA-14-14-2)预防瑞士白化病小鼠日本脑炎的比较研究

获取原文
           

摘要

Objectives: Vaccination is the only means present with us to fight Japanese encephalitis which is widespread in South-East Asian countries as there is no effective treatment at present. However, vaccination of rural mass population in this specified region is extremely complex due to climatic, geographical, socio-economical barriers. In this study we explored possible use of “Belladonna-200” –an easily applicable homeopathic medicine to prevent this important disease.Methods: In this experiment initially adult mice JE virus adaptation was achieved by repeated passage of the virus and 50% lethal dose (LD50) of the virulent Nakayama strain virus was calculated by successive experiments with several lots of mice (6 to 8 wks age). Following this 63 adult mice (control group) were challenged with the virus by a standardized intracerebral inoculation technique, similarly 33 mice which were fed with “Belladonna- 200” (experimental group) and 28 mice (vaccine control group) which were protected by the Japanese Encephalitis Live Vaccine (SA14-14-2), were also challenged with the same doses of the virus.Results: The results confirmed a definite protective action of “Belladonna 200” against JE which was almost equal to the protective action of Japanese Encephalitis Live Vaccine (SA14-14-2).Conclusion: Considering the insignificant expenditure of this medicine which can be administered orally without any side effects, “Belladonna- 200” appears to be an important alternative to the vaccine..
机译:目标:疫苗接种是我们目前对抗日本脑炎的唯一手段,由于目前尚无有效的治疗方法,因此在东南亚国家中流行。但是,由于气候,地理和社会经济方面的障碍,该特定地区农村群众的疫苗接种极为复杂。在这项研究中,我们探索了可能容易使用的顺势疗法药物“ Belladonna-200”来预防这种重要疾病的方法。方法:在本实验中,成年小鼠JE病毒的适应性是通过病毒的反复传代和50%致死剂量(通过对几只小鼠(6至8周龄)的连续实验,计算出有毒的中山毒株病毒的LD50。在这63只成年小鼠(对照组)之后,通过标准化的脑内接种技术对病毒进行了攻击,类似地,给33只小鼠喂食了“ Belladonna-200”(实验组)和28只小鼠(对照组),这些小鼠受到了这种病毒的保护。还用相同剂量的病毒对日本脑炎活疫苗(SA14-14-2)进行了攻击。结果:结果证实“ Belladonna 200”对JE的确切保护作用几乎等于日本脑炎的保护作用活疫苗(SA14-14-2)。结论:考虑到这种药物的口服费用微不足道,没有任何副作用,因此“ Belladonna- 200”似乎是该疫苗的重要替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号